RVPH Long Call Strategy

RVPH (Reviva Pharmaceuticals Holdings, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attention–deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company is headquartered in Cupertino, California.

RVPH (Reviva Pharmaceuticals Holdings, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.2M, a beta of 0.75 versus the broader market, a 52-week range of 0.26-23.2, average daily share volume of 599K, a public-listing history dating back to 2018, approximately 14 full-time employees. These structural characteristics shape how RVPH stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.75 places RVPH roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a long call on RVPH?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current RVPH snapshot

As of May 15, 2026, spot at $12.63, ATM IV 352.70%, IV rank 91.49%, expected move 101.12%. The long call on RVPH below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.

Why this long call structure on RVPH specifically: RVPH IV at 352.70% is rich versus its 1-year range, which makes a premium-buying RVPH long call relatively expensive in absolute-cost terms, with a market-implied 1-standard-deviation move of approximately 101.12% (roughly $12.77 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated RVPH expiries trade a higher absolute premium for lower per-day decay. Position sizing on RVPH should anchor to the underlying notional of $12.63 per share and to the trader's directional view on RVPH stock.

RVPH long call setup

The RVPH long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With RVPH near $12.63, the first option leg uses a $12.63 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed RVPH chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 RVPH shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$12.63N/A

RVPH long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

RVPH long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on RVPH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on RVPH

Long calls on RVPH express a bullish thesis with defined risk; traders use them ahead of RVPH catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

RVPH thesis for this long call

The market-implied 1-standard-deviation range for RVPH extends from approximately $-0.14 on the downside to $25.40 on the upside. A RVPH long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current RVPH IV rank near 91.49% sits in the upper third of its 1-year distribution, which historically reverts; this raises the bar for premium-buying structures and lowers it for premium-selling structures on RVPH at 352.70%. As a Healthcare name, RVPH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to RVPH-specific events.

RVPH long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. RVPH positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move RVPH alongside the broader basket even when RVPH-specific fundamentals are unchanged. Long-premium structures like a long call on RVPH are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current RVPH chain quotes before placing a trade.

Frequently asked questions

What is a long call on RVPH?
A long call on RVPH is the long call strategy applied to RVPH (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With RVPH stock trading near $12.63, the strikes shown on this page are snapped to the nearest listed RVPH chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are RVPH long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the RVPH long call priced from the end-of-day chain at a 30-day expiry (ATM IV 352.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a RVPH long call?
The breakeven for the RVPH long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current RVPH market-implied 1-standard-deviation expected move is approximately 101.12%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on RVPH?
Long calls on RVPH express a bullish thesis with defined risk; traders use them ahead of RVPH catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current RVPH implied volatility affect this long call?
RVPH ATM IV is at 352.70% with IV rank near 91.49%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.

Related RVPH analysis